Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | HBB | P68871 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7662112 | 0.81 | ALDH1A1 (0.54) | ALDH1A1MEN1LMNABLMHBB | |
| SCHEMBL3862398 | 0.81 | ALDH1A1 (0.54) | ALDH1A1MEN1LMNABLMHBB | |
| SCHEMBL7670645 | 0.79 | ALDH1A1 (0.52) | ALDH1A1 | |
| SCHEMBL2015730 | 0.77 | ALDH1A1 (0.50) | ALDH1A1HIF1A | |
| SCHEMBL13685884 | 0.77 | ALDH1A1 (0.50) | ALDH1A1HIF1A | |
| SCHEMBL7761443 | 0.76 | ALDH1A1 (0.48) | ALDH1A1LMNA | |
| SCHEMBL7772642 | 0.76 | ALDH1A1 (0.48) | ALDH1A1 | |
| SCHEMBL7761721 | 0.76 | ALDH1A1 (0.48) | ALDH1A1LMNA | |
| SCHEMBL7883063 | 0.73 | ALDH1A1 (0.62) | ALDH1A1MEN1LMNABLMHBB | |
| SCHEMBL7665015 | 0.73 | ALDH1A1 (0.45) | ALDH1A1MEN1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6365611-B1 | HYDROPHILIC NITRATE VASODILATORS | ISIS PHARMA GMBH (DE) | 2002-04-02 | — | — | US | disclosed |
| EP-1087926-A2 | ANALYTIC SUBSTRATES AND ANTIOXIDATIVE AGENTS | Alpharma-Isis GmbH & Co. KG (DE) | 2001-04-04 | — | — | EP | disclosed |
| US-6180664-B1 | CARDIOVASCUALR DISORDERS; IMPOTENCY | ISIS PHARMA GMBH (DE) | 2001-01-30 | — | — | US | disclosed |
| EP-1009730-A1 | NEW PENTAERYTHRITOL DERIVATIVES, THEIR PRODUCTION AND USE AND INTERMEDIATES FOR THEIR SYNTHESIS | ISIS PHARMA GmbH (DE) | 2000-06-21 | — | — | EP | disclosed |
| EP-0988282-A2 | NOVEL PENTAERYTHRITE DERIVATIVES, THE PRODUCTION AND USE THEREOF AND INTERMEDIATE PRODUCTS FOR THE SYNTHESIS OF THE SAME | ISIS PHARMA GMBH (DE) | 2000-03-29 | — | — | EP | disclosed |
| WO-1999067430-A2 | ANALYTIC SUBSTRATES AND ANTIOXIDATIVE AGENTS | ALPHARMA-ISIS GMBH & CO. KG (DE) | 1999-12-29 | — | — | WO | disclosed |
| WO-1998056759-A2 | NOVEL PENTAERYTHRITE DERIVATIVES, THE PRODUCTION AND USE THEREOF AND INTERMEDIATE PRODUCTS FOR THE SYNTHESIS OF THE SAME | ISIS PHARMA GMBH (DE) | 1998-12-17 | — | — | WO | disclosed |
| WO-1998015521-A1 | NEW PENTAERYTHRITOL DERIVATIVES, THEIR PRODUCTION AND USE AND INTERMEDIATES FOR THEIR SYNTHESIS | ISIS PHARMA GMBH (DE) | 1998-04-16 | — | — | WO | disclosed |